 |
William Sandborn, MD |
|
|
|
Take Posttest
Online and Print Your
Certificate Instantly! |
Download Posttest
and Fax or Mail Back |
|
 |
|
New Biologics in the Treatment of Crohn's Disease —William Sandborn, MD, Executive Editor |
|
Part 1: |
Advances in Treatment with the New Biologics —Stephen Hanauer, MD |
- for reference only, not for CME credit |
|
Part 2: |
New Targets for Disease Modification: Anti–Alpha4 Integrin Therapy —William Sandborn, MD |
- for reference only, not for CME credit |
|
Part 3: |
Maximizing Outcomes in Crohn's Disease —Brian Feagan, MD |
- for reference only, not for CME credit |
|
 |
|
Treatment of Ulcerative Colitis —William Sandborn, MD, Executive Editor |
| |
Part 1: |
Natural History, Outcomes, and Prognosis —William Sandborn, MD |
- for reference only, not for CME credit |
|
Part 2: |
Advances in 5-ASA Therapy —Gary Lichtenstein, MD |
- for reference only, not for CME credit |
|
Part 3: |
New Options for Improving Patient Compliance —Sunanda Kane, MD, MSPH |
- for reference only, not for CME credit |
|
Part 4: |
The Role of Mesalamine Therapy in Prevention of UC-Related Colorectal Cancer
Prostate Cancer —David Rubin, MD |
- for reference only, not for CME credit |
|
 |
|
Redefining Treatment in Ulcerative Colitis —William Sandborn, MD, Executive Editor |
| |
Part 1:
|
Making Sense of Multiple Options: The 5-ASAs
|
- for reference only, not for CME credit |
| |
Part 2:
|
Pharmacodynamics and Pharmacokinetics of 5-ASA Formulations
|
- for reference only, not for CME credit |
| |
Part 3:
|
Examining the Ulcerative Colitis–Colorectal Cancer Link
|
- for reference only, not for CME credit |
| |
Part 4:
|
Individualizing Treatment
|
Take test now |
Download |
|
|
|
|
|